Compounds > pyrroles
Page last updated: 2024-08-18

pyrroles and Dermatitis, Allergic Contact

pyrroles has been researched along with Dermatitis, Allergic Contact in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liszewski, W; Warshaw, EM1
Fujii, Y; Sengoku, T1
Bäumer, W; Cook, E; Ehling, S; Fukuyama, T1
Amano, W; Kabashima, K; Matsushita, M; Miyachi, Y; Nakajima, S; Tanimoto, A; Yamamoto, Y1

Other Studies

4 other study(ies) available for pyrroles and Dermatitis, Allergic Contact

ArticleYear
Pigments in American tattoo inks and their propensity to elicit allergic contact dermatitis.
    Journal of the American Academy of Dermatology, 2019, Volume: 81, Issue:2

    Topics: Anthraquinones; Azo Compounds; Carbon; Coloring Agents; Dermatitis, Allergic Contact; Heterocyclic Compounds, 4 or More Rings; Humans; Indenes; Ink; Ketones; Metals; Product Labeling; Pyrroles; Quinolines; Tattooing; United States

2019
Effects of the Janus kinase inhibitor CP-690550 (tofacitinib) in a rat model of oxazolone-induced chronic dermatitis.
    Pharmacology, 2013, Volume: 91, Issue:3-4

    Topics: Animals; Anti-Inflammatory Agents; Cytokines; Dermatitis, Allergic Contact; Ear; Female; Hyperplasia; Janus Kinases; Oxazolone; Piperidines; Pyrimidines; Pyrroles; Rats; Rats, Sprague-Dawley; Skin

2013
Topically Administered Janus-Kinase Inhibitors Tofacitinib and Oclacitinib Display Impressive Antipruritic and Anti-Inflammatory Responses in a Model of Allergic Dermatitis.
    The Journal of pharmacology and experimental therapeutics, 2015, Volume: 354, Issue:3

    Topics: Administration, Oral; Administration, Topical; Animals; Anti-Inflammatory Agents; Antipruritics; Cytokines; Dermatitis, Allergic Contact; Disease Models, Animal; Female; Inflammation; Janus Kinases; Lymph Nodes; Mice; Mice, Inbred BALB C; Piperidines; Pruritus; Pyrimidines; Pyrroles; Skin; Sulfonamides

2015
JAK inhibitor JTE-052 regulates contact hypersensitivity by downmodulating T cell activation and differentiation.
    Journal of dermatological science, 2016, Volume: 84, Issue:3

    Topics: Administration, Oral; Animals; Antigen Presentation; Cell Differentiation; Cell Movement; Cell Proliferation; Croton Oil; Dendritic Cells; Dermatitis, Allergic Contact; Drug Evaluation, Preclinical; Female; Haptens; Inflammation; Interferon-gamma; Interleukin-13; Interleukin-17; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Protein Kinase Inhibitors; Pyrroles; Skin; T-Lymphocytes

2016